Federal Register / Vol. 65, No. 120 / Wednesday, June 21, 2000 / Notices 38559

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration;

Statement of Organization, Functions,

and Delegations of Authority

Part F, of the Statement of

Organization, Functions, and

Delegations of Authority of the

Department of Health and Human

Services, Health Care Financing

Administration (HCFA), 49 FR 34247,

dated September 6, 1984, is amended to

include the following delegation of

authority from the Secretary to the

Administrator, HCFA, for carrying out

Title XXII of the Public Health Service

Act, as amended.

• Section F.30., Delegations of

Authority is amended by adding the

following paragraph:

vv. The authority vested in the

Secretary by Title XXII of the Public

Health Service Act, as amended.

This delegation shall be exercised

under the Department’s policy on

issuance of regulations. In addition, I

hereby affirm and ratify any actions

taken by the Administrator, or other

HCFA officials which, in effect,

involved the exercise of this authority

prior to the effective date of this

delegation. This delegation is effective

immediately, and may be further

redelegated. This delegation of authority

supersedes the memorandum from the

Secretary to the Assistant Secretary for

Health, dated March 2, 1987, entitled

‘‘Delegation of Authority for Title XXII

of the Public Health Service Act, Public

Law 99–272, Section 10003.’’

Dated: June 12, 2000.

Donna E. Shalala,

Secretary.

[FR Doc. 00–15549 Filed 6–20–00; 8:45 am]

BILLING CODE 4120–03–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[Program Announcement 00117]

Prevention and Control of

Micronutrient Malnutrition; Notice of

Availability of Funds

A. Purpose

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 2000

funds for a cooperative agreement

program for the Prevention and Control

of Micronutrient Malnutrition.

B. Eligible Applicant(s)

Single Source

Assistance will be provided only to

the United Nations Children’s Fund

(UNICEF), New York, New York. No

other applications are solicited.

UNICEF is the most appropriate and

qualified agency to conduct the

activities under this cooperative

agreement because:

1. UNICEF is the only organization

that has country-based offices to support

direct delivery of public health

programs and services in nearly every

country in the world. Additionally,

UNICEF’s mandate addresses issues

other than health, e.g., education; and

this has enabled UNICEF programs to

advocate more effectively for

micronutrient deficiency intervention

programs across multiple sectors of

society because of the significant impact

of such programs on health as well as

education of populations. In addition to

national offices, UNICEF supports subnational programs which allow it direct

access to local public health and

education programs.

2. UNICEF supports micronutrient

deficiency intervention programs

around the world through the

distribution of vitamin A capsules, as

well as iron and folic acid supplements

to target populations. UNICEF supports

country-based salt iodization programs

around the world to reduce the burden

of iodine deficiency disorders.

3. The proposed program is strongly

supportive of, and directly related to,

the achievement of UNICEF and the

CDC/Micronutrient Malnutrition

Program objectives for the prevention

and control of micronutrient

malnutrition.

C. Availability of Funds

Approximately $700,000 is available

in FY 2000 to fund one award. It is

expected that the award will begin on or

about September 30, 2000, and will be

made for a 12-month budget period

within a project period of up to two

years.

D. Where To Obtain Additional

Information

Business management technical

assistance may be obtained from: Van A.

King, Grants Management Specialist,

Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), Announcement [00117], 2920

Brandywine Road, Room 3000, Atlanta,

GA 30341, Telephone Number (770)

488–2751, Email Address

vbk5@cdc.gov.

Program technical assistance may be

obtained from: Ibrahim Parvanta,

Division of Nutrition and Physical

Activity, National Center for Chronic

Disease Prevention, Centers for Disease

Control and Prevention, 4770 Buford

Highway, MS K–25, Atlanta, GA 30341–

3724, Telephone Number (770) 488–

5865, Email Address ixp1@cdc.gov.

Dated: June 14, 2000.

Henry S. Cassell, III,

Acting Director, Procurement and Grants

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 00–15584 Filed 6–20–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

The National Center for Environmental

Health (NCEH) of the Centers for

Disease Control and Prevention (CDC)

Announces the Following Meeting

Name: Public Meeting to Review and Reevaluate Safe Airborne Exposure Limits

(AELs) of Nerve Agents GA, GB and VX.

Time and Dates: 8 am–5 pm, Wednesday,

August 23, 2000.

8 am–5 pm, Thursday, August 24, 2000.

Place: J.W. Marriott Hotel, 3300 Lenox

Road NE, Atlanta, GA 30326, telephone 404/

262–3344. For overnight accommendations, a

special room rate is available until Friday,

July 21, 2000.

Status: Open to the public, limited only by

space available. The meeting room

accommodates approximately 100 people.

Background: Chemical warfare materials

agents GA, GB, and VX are no longer

manufactured in the U.S.; however, they

currently are stored at 8 locations in the

continental U.S. by the Department of

Defense (DOD). Public Law (Pub. L.)99–145

(50 U.S.C. 1521) mandates that these

stockpiled lethal chemical agents be

destroyed. In 1970, Pub. L. 91–121 and Pub.

L. 91–441 (50 U.S.C. 1521) mandated that the

Department of Health and Human Services

must review DOD plans for disposing of the

munitions and make recommendations to

protect human health. In 1987, CDC

requested public comment on

recommendations for protecting human

health and the environment against potential

adverse effects of long-term exposure to low

doses of agents: G, GB, VX, Mustard (H, HD,

T) and Lewisite (L). CDC incorporated the

public comments and in 1988 recommended

control limits for air exposures to agents GA,

GB, and VX for protection of workers

involved in the demilitarization process and

for the general public living in areas adjacent

to demilitarization facilities. The Army

adopted these control limits into policy in

1990. Now, twelve years later, CDC is

recommending that these control limits be reevaluated based on newly developed risk